Biogen (BIIB) Accumulated Expenses (2010 - 2012)

Biogen has reported Accumulated Expenses for 3 years, with the latest figure at $156.7 million in Q2 2012.

• On a quarterly basis, Accumulated Expenses changed N/A year-over-year to $156.7 million in Q2 2012; TTM through Jun 2012 was $156.7 million, a N/A change from a year earlier, with the FY2011 full-year figure at $176.3 million, up 10.39% from the prior year.
• Accumulated Expenses was $156.7 million for Q2 2012 at Biogen, up from $108.5 million in the prior quarter.
• The five-year high for Accumulated Expenses was $176.3 million in Q4 2011, with the low at $108.5 million in Q1 2012.
• Average Accumulated Expenses over 3 years is $150.3 million, with a median of $158.2 million recorded in 2010.
• The largest YoY upside for Accumulated Expenses was 10.39% in 2011 against a maximum downside of 10.39% in 2011.
• Over 3 years, Accumulated Expenses stood at $159.7 million in 2010, then increased by 10.39% to $176.3 million in 2011, then dropped by 11.12% to $156.7 million in 2012.
• The last three Accumulated Expenses figures came in at $156.7 million (Q2 2012), $108.5 million (Q1 2012), and $176.3 million (Q4 2011), per Business Quant data.